Brief: Harvard Apparatus Regenerative Technology sauys selling stockholder Aspire Capital Fund may sell up to 2.7 mln shares
29/12/2015 21:48
Dec 29 (Reuters) - Harvard Apparatus Regenerative Technology Inc HART.O : * Selling stockholder Aspire Capital Fund may sell up to 2.7 million shares of co's common stock * Source text for Eikon ID:nEOL1Yhp0w * Further company coverage HART.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Harvard Apparatus Regenerative Technology
See all newsBrief: Harvard Apparatus Regenerative Technology Announces Strategic Collaboration With Children’S Hospital Capital Institute Of Pediatrics In Beijing, China To Advance Treatment For Esophageal Atresia
Brief: Biostage Activated Mayo Clinic As The First Site For Clinical Trial In Severe Esophageal Disease
Brief: Biostage Amends CEO Employment Agreement
Brief: Biostage Inc Files For Firm Commitment Public Offering Of 1.03 Million Units - SEC Filing
Brief: Biostage Announces Appointment Of New Chief Financial Officer